Just two weeks ago, I brought 13 practices to market, and here’s the surprising part: five of them had previously been told “no” by corporate buyers, yet now they’re on the radar.  In this blog, I’m pulling back the curtain on what shifted—what took these practices from “not viable” to “in the running.” If you’ve ever been told your practice isn’t a fit for corporate acquisition, this might change your perspective.